key: cord-0851213-vadz39jw
authors: Huyut, Mehmet Tahir; Üstündağ, Hilal
title: Prediction of diagnosis and prognosis of COVID-19 disease by blood gas parameters using decision trees machine learning model: a retrospective observational study
date: 2021-10-19
journal: Med Gas Res
DOI: 10.4103/2045-9912.326002
sha: 3a89c311f00faf14446d425aaf8fa1937b1f2ae3
doc_id: 851213
cord_uid: vadz39jw

The coronavirus disease 2019 (COVID-19) epidemic went down in history as a pandemic caused by corona-viruses that emerged in 2019 and spread rapidly around the world. The different symptoms of COVID-19 made it difficult to understand which variables were more influential on the diagnosis, course and mortality of the disease. Machine learning models can accurately assess hidden patterns among risk factors by analyzing large-datasets to quickly predict diagnosis, prognosis and mortality of diseases. Because of this advantage, the use of machine learning models as decision support systems in health services is increasing. The aim of this study is to determine the diagnosis and prognosis of COVID-19 disease with blood-gas data using the Chi-squared Automatic Interaction Detector (CHAID) decision-tree-model, one of the machine learning methods, which is a subfield of artificial intelligence. This study was carried out on a total of 686 patients with COVID-19 (n = 343) and non-COVID-19 (n = 343) treated at Erzincan-Mengücek-Gazi-Training and Research-Hospital between April 1, 2020 and March 1, 2021. Arterial blood gas values of all patients were obtained from the hospital registry system. While the total-accuracyratio of the decision-tree-model was 65.0% in predicting the prognosis of the disease, it was 68.2% in the diagnosis of the disease. According to the results obtained, the low ionized-calcium value (< 1.10 mM) significantly predicted the need for intensive care of COVID-19 patients. At admission, low-carboxyhemoglobin (< 1.00%), high-pH (> 7.43), low-sodium (< 135.0 mM), hematocrit (< 40.0%), and methemoglobin (< 1.30%) values are important biomarkers in the diagnosis of COVID-19 and the results were promising. The findings in the study may aid in the early-diagnosis of the disease and the intensive-care treatment of patients who are severe. The study was approved by the Ministry of Health and Erzincan University Faculty of Medicine Clinical Research Ethics Committee.

The coronavirus disease 2019 (COVID-19) epidemic, which emerged in Wuhan, China at the end of 2019 and caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread rapidly around the world and went down in history as the first pandemic caused by corona viruses 1 . The mechanism of damage caused by SARS-CoV-2 virus in cells, tissues and organs is not fully known. It is characterized by severely atypical respiratory distress in patients with COVID-19 and hypoxemia, which may precede radiological changes or other clinical symptoms, including dyspnea. 2 Hypoxemia in COVID-19 is severe and ultimately is the primary mechanism of multi-organ failure and death. 3 The underlying pathology is due to the entry of COVID-19 into cells via the angiotensin-converting enzyme 2 receptor. This receptor is expressed in many cells, including alveolar epithelial cells and vascular endothelium, which can result in a profound immune response and widespread endothelial dysfunction. 4 The diagnosis and treatment of most respiratory system diseases largely depends on an understanding of the basic physiological principles of respiration and gas exchange.

While some of the respiratory system diseases are caused by ventilation failure; others result from the pulmonary membrane, diffusion disorders, or defects in the transport of gases in the blood between the lungs and tissues. 5 Blood partial pressure of oxygen, partial pressure of carbon dioxide, and pH values obtained from blood gases, which are frequently preferred in the diagnosis, treatment and follow-up of respiratory and metabolic diseases, are among the important tests used to examine lung functions. [5] [6] [7] Today, machine learning (ML) is used in many fields such as object recognition, image processing, face recognition, virtual reality, augmented reality, voice recognition, iris recognition, marketing, health, customer service, satellite images, earth science, fraud detection (fraud). It is a subfield and the largest branch of artificial intelligence (AI). It is seen that AI technologies, which have been used with great success in many fields in recent years, have started to be used frequently in the diagnosis, prognosis and treatment processes of diseases, especially in the field of medicine. The most important reason for this is the power of ML algorithms, which are under AI technologies and accepted as an important part of data mining, to reveal hidden relationships between patterns. In this way, serious success can be achieved in the diagnosis of diseases that show similar symptoms, have intense uncertainties and are difficult to distinguish from each other. For example, data mining approaches applied to medical science topics are rapidly being developed due to their high performance in predicting outcomes, reducing drug costs, improving patient health, improving healthcare value and quality, and making real-time decisions to save people's lives. 8 In developed countries, AI research departments associate with hospital to carry out the studies on the "Research and Development," because the developments in AI technologies not only impacts patients and doctors but also the entire health system. In particular, "Artificial Intelligence in Medicine" has been defined as a branch of computer science it has the capacity to analyze complex medical data and help physicians improve patient outcomes. Considering the number of data constantly included in the system in hospitals, information processing capabilities beyond human capacity are needed in order to manage such large data. Today, thanks to AI technologies, predictive discoveries can be made by processing blood, urine and other laboratory samples from patients with powerful learning algorithms. Thanks to these discoveries, the physician can now be more accurate and safe when making a decision about the patient.

In this study, the diagnosis and prognosis of COVID-19 disease was determined by blood gas data using decision trees model from ML algorithms, which is a subfield of AI. It is thought that the results obtained from this study will guide clinicians in diagnosis and prediction of disease progression and useful strategic issues.

This retrospective observational study was conducted taking into account the Declaration of Helsinki and was approved by the Ministry of Health of the Republic of Turkey and the Clinical Research Ethics Committee of Erzincan Binali Yıldırım University Faculty of Medicine (Ruling No. E-21142744-804.99-70855) on March 23, 2020. Between May 1, 2020 and March 1, 2021, data in accordance with our criteria were collected from the information system of Erzincan Binali Yıldırım University Mengücek Gazi Training and Research Hospital and included in the study. The study only included individuals over the age of 18 years. The laboratory information of the patients participating in the study was the first blood values measured at hospital admission. Informed consent was obtained from all individuals included in this study. This study follows the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement (Additional file 1).

Three different patient groups who applied to the Training and Research Hospital of our university between May 2020 and March 2021 were included in this study. First group: those diagnosed with COVID-19 and admitted to the intensive care unit (ICU); Second group: Those diagnosed with COVID-19 and treated in wards outside the intensive care unit (non-ICU); Third group: Patients who were not diagnosed with COVID-19 but had different etiologies and respiratory distress (Control group). Blood gas laboratory data of all patient groups were retrospectively analyzed by file scanning. A total of 686 patients, including 131 treated in the ICU unit, 212 treated in non-ICU units, and 343 individuals in the control group, were included in the study according to the criteria determined. COVID-19 was diagnosed in our hospital only in cases where SARS-CoV-2 was detected by real-time polymerase chain reaction in nasopharyngeal or oropharyngeal swabs during the dates covered by this study.

The workflow of this study consists of two stages. In the first step, Chi-squared Automatic Interaction Detector (CHAID) decision tree algorithm was run to predict the prognosis of the disease (separating non-ICU from ICU) with blood gas parameters. In the second stage, CHAID decision tree algorithm was run to predict the diagnosis of the disease (differentiating patients with COVID-19 from patients with non-COVID-19) using blood gas parameters. Blood gas biomarkers that are effective in the diagnosis and prognosis of the disease were determined by decision tree regression analysis and cut-off values were calculated.

Age, gender and arterial blood gas; P50 (oxygen tension when hemoglobin is 50% saturated with oxygen), bicarbonate plasma, bilirubin, deoxyhemoglobin, glucoce, HCO 3 , hematocrit, hemoglobin, carboxyhemoglobin, chlorine, lactate, methemoglobin, oxyhemoglobin, oxygen saturation, osmalarite, pH, potassium, sodium, standard base, total O 2 , partial pressure of carbon dioxide, partial pressure of oxygen, ionized calcium (iCa) values of the patient and control groups in this study were obtained. Arterial blood gas samples were analyzed and digitally recorded on ABL 700 (Radiometer, Copenhagen, Denmark).

The first aim of this study is to predict the prognosis of the disease (differentiating out of ICU and intensive care unit) by blood gas parameters. Our secondary aim is to predict the diagnosis of the disease (differentiating patients with COVID-19 from patients with non-COVID-19) with blood gas parameters. With this methodology, the diagnosis and prognosis of CO-VID-19 is determined by the blood gas values measured at the time of admission of the patients.

CHAID decision tree method is a non-parametric method that can analyze nominal and quantitative variables together, provides highly reliable predictions on large data sets, and can be used as an alternative to logistic regression models. Besides these benefits, it can detail the relationship structures between predictive variables and provide efficient and understandable tree-like outputs even in complex data structures. With this superiorty, CHAID decision tree method has a large range of uses. 9, 10 Preparation of the data set After data completion, training and test sets were determined by 10-fold cross validation on the measured properties dataset. In addition, the advantage of cross validation was used to www.medgasres.com minimize the risk of overfitting in the evaluation of training and test sets. This procedure allowed for unbiased generalization estimation while determining the parameters of the decision tree model. 9 Then, the optimum hyperparameters of the decision tree model were determined by grid search. Non-ICU and ICU patients with COVID-19 were selected as the dependent variable when predicting the prognosis of the disease. When determining the diagnosis of the disease, groups with COVID-19 and non-COVID-19 (Control group) were selected as dependent variables. In addition, a balanced data set was created to increase the success performance of the decision tree model in the diagnosis of COVID-19, and an equal number of patients were included in the COVID-19 group and the non-COVID-19 (Control) group.

SPSS Statistics 25 (IBM, Armonk, NY, USA) software was used for statistical analysis. Categorical variables were analyzed with the chi-square test and continuous variables were analyzed with the Mann-Whitney U test. The CHAID algorithm, one of the Decision Trees analysis methods, was used. P < 0.05 was considered statistically important. All blood gas parameters obtained as a result of the measurement and age and gender variables of the patients were included in the decision tree model, which was run to determine the variables affecting the diagnosis and prognosis of COVID-19.

The demographic data of this study population are summarized in Figure 1 . Of the 131 ICU group patients included in the study, 80 (61.1%) were male and 51 (38.9%) female; of the 212 non-ICU group patients, 122 (57.5%) were male and 90 (42.5%) female; of the 343 control group patients, 209 (60.9%) were male and 134 (39.1%) female (Figure 1) .

The gender variable was not found to be significant among the patient groups (P > 0.669). Data regarding the age distribution of the study groups are summarized in Table 1 . The mean age of the patients in the ICU and non-ICU groups was higher than the control group (P < 0.05). However, there was no significant difference between the ages of the ICU and non-ICU groups (P > 0.15) ( Table 1) .

In this research, the CHAID decision tree diagram obtained to identify the blood gas predictors that ınfluenced the prognosis of COVID-19 disease (separating non-ICU from the ICU) is presented in Figure 2 . When the decision tree diagram in Figure 2 was investigated, 212 (61.8%) of the COVID-19 patients included in the study were non-ICU and 131 (38.2%) were ICU patients. The "ionized calcium" blood gas parameter was found to be the most efficient predictor of the prognosis of the disease (χ 2 = 25.027, P < 0.001; Figure 2) . Accordingly, COVID-19 patients are divided into two different groups according to the ionized calcium variable whose cut-off value is determined. According to these findings, 1.10 and lower "ionized calcium" values increases the prognosis of patients COVID-19 significantly (27.1% vs. 53.9%). In addition, constructing our decision tree with the "ionized calcium" variable to determine disease progression demonstrated the clinical accuracy of our interpretable decision tree (Figure 2) .

The classification success rate of the decision tree model, which was created to predict the prognosis of the disease with only the "ionized calcium" variable, was 65.0% and it was found to be statistically significant ( Table 2) . Accordingly, 69.3% of non-ICU patients and 58.0% of ICU patients were predicted correctly by considering only the cut-off value of the "ionized calcium" variable ( Table 2) . 

In this manuscript, the CHAID decision tree diagram was constructed to identify the blood gas predictors that influence the detection of COVID-19 (separating the COVID-19 patients from the Control group) (Figure 3) . When the decision tree diagram in Figure 3 was investigated, 343 (50.0%) of 686 patients were in the COVID-19 group and 343 (50.0%) were in the Control group. It was seen that the most effective blood gas variable on the diagnosis of the disease is "carboxyhemoglobin" (χ 2 = 76.698, P < 0.001; Figure 3) . The presence of Carboxyhemoglobin (and subsequently pH, sodium, hematocrit, methemoglobin) at the root of the decision tree ensures the clinical accuracy of our interpretable Decision Tree ( Figure  3 ) regarding the robustness of the approach to determining the diagnosis of the disease. According to the diagnosis of COVID-19, the "carboxyhemoglobin" variable was divided into three different groups in our decision tree. While the "carboxyhemoglobin" value of 7.3% of the individuals in the study could not be reached, 92.7% were classified according to cut-off values of ≤ 1.00, (1.00-1.60) and > 1.60. When Figure 3 was examined, 62.0% of individuals with a "carboxyhemoglobin" value of ≤ 1.00, 43.9% of (1.00-1.60), and 24.0% of individuals with > 1.60 were COVID-19 patients, respectively. According to these findings, low Carboxyhemoglobin value was found to be an important biomarker in the diagnosis of the disease. In addition, the most influential variables in the diagnosis of COVID-19 in individuals with three different "carboxyhemoglobin" values were pH (χ 2 = 21.765, P < 0.001), sodium (χ 2 = 10.574, P < 0.05) and hematocrit (χ 2 = 10.574, P < 0.05). In three different "carboxyhemoglobin" groups, individuals with > 7.43 pH, ≤ 135.00 mM sodium and ≤ 40.0% hematocrit values, respectively, had more COVID-19 disease (84.7%, 59.2%, 37.0%, respectively). In addition, "methemoglobin" was the most influential variable in the diagnosis of COVID-19 diseases in individuals with a carboxyhemoglobin value of ≤ 1.00 and a pH value of ≤ 7.43 (χ 2 = 9.585, P < 0.05). In accordance with the findings, the rate of having COVID-19 in individuals with a methemoglobin value of ≤ 1.30 was 65.9%, while this rate was 43.4% in individuals with a value of > 1.30. According to this, high pH, low sodium, hematocrit and methemoglobin values were found to be the most important biomarkers in the diagnosis of COVID-19 after low "carboxyhemoglobin" value.

The classification success of the decision tree model obtained in order to predict the COVID-19 diagnosis of individuals within the scope of the study is presented in Table 3 . The overall classification success rate of the decision tree model, which was created with only five variables, was 68.2% and it was statistically significant ( Table 3 ). In addition, 59.5% of 343 COVID-19 individuals and 77.0% of 343 non-COVID-19 individuals were predicted correctly, considering the cut-off value of carboxyhemoglobin, hematocrit, sodium, pH and methemoglobin variables with the decision tree model established for the diagnosis of the disease ( Table 3) . 

The symptoms of COVID-19 are very similar to the common flu, which includes fever, cough and nasal congestion. 11 As the pandemic spread, other symptoms emerged, such as loss of taste and smell (anosmia). 12, 13 Severe cases can lead to serious respiratory illness and pneumonia. Those most at risk are the elderly and people with underlying medical problems/comorbid diseases such as cardiovascular diseases and diabetes. 14, 15 As the disease spreads around the world, more symptoms and features are being noticed that affect patient deaths. Having such a broad set of features affected by the disease makes it difficult to understand which variables have a greater impact on disease mortality. ML models can analyze large datasets to identify diseases, predict progression and mortality, and can be used to help accurately assess risk factors. It was studied on patients who were hospitalized in the intensive care unit with the diagnosis of COVID-19, were diagnosed with COVID-19 and were treated in non-ICU services, were not diagnosed with COVID-19, but had a different etiology and respiratory disease (control group). Based on the arterial blood gas test results of these three patient groups, decision trees (Figures 2 and 3) were obtained with the CHAID algorithm, which can be used for guidance in cases of doubt in the detection and progression of COVID-19, by evaluating predictors together. 10 In this study, COVID-19 patients were importantly older than the control group. The high correlation between advanced age and disease was found to be consistent with the literature. 10 In addition, age was included in the decision tree models in the study, as it was found to be an important predictor in the determination and progression of the disease. [15] [16] [17] [18] Although iCa constitutes about half of the calcium level in the circulatory system, it is a free form that is metabolically active and not bound to proteins. Since the circulating ionized level is a better indicator than the total level, it is a more useful parameter in clinical terms. For this reason, it is requested by clinicians, especially to evaluate the follow-up or treatment of critically ill patients. 19 In this study, the most important arterial blood gas variable affecting the prognosis of COVID-19 disease was "ionized calcium" (Figure 2) . The overall classification accuracy of the decision tree, which was modeled significantly only with the ionized calcium variable to predict the progression of COVID-19, was 65.0%. Accordingly, 69.3% of non-ICU patients and 58.0% of ICU patients were predicted correctly ( Table 2) . Other arterial blood gas values were not found to be important in predicting the progression of COVID-19. In this manuscript, "ionized calcium" values (≤ 1.10 mM) significantly predicted the need for intensive care in COVID-19 patients.

Although it was emphasized in one study that "methemoglobin" and "carboxyhemoglobin" levels may be associated with the severity of sepsis, these levels were not associated with the prognosis of COVID-19. 20 In another study, it was stated that carboxyhemoglobin alone cannot be used to diagnose pneumonia of COVID-19 or to predict disease severity. 21 In another study, low methemoglobin and carboxyhemoglobin values were observed at the beginning of the disease, and it was stated that these values were expected to increase with the progression of the disease. However, it was stated that both variables and their clinical consequences should be further investigated and followed in severe patients. 22 In addition, studies on intensive care patients indicated that low carboxyhemoglobin levels were associated with high mortality. In another study, it was stated that low carboxyhemoglobin level at admission in COVID-19 patients is a biomarker that can guide early follow-up and treatment planning to prevent severe acute respiratory distress syndrome and mortality. 23 In this study, the most substantial arterial blood gas variable in determining the disease was carboxyhemoglobin. After that, arterial blood values of sodium, pH, hematocrit and methemoglobin were found to be important in determining the disease. Low carboxyhemoglobin (< 1.00%), high pH (> 7.43), low sodium (< 135.0 mM), hematocrit (< 40.0%), and methemoglobin (< 1.30%) values were significant independent markers in detecting COVID-19. It was noteworthy that blood gas variables that were found to be important in determining COVID-19 were not considered significant in the progression of the disease. Arterial blood gas variables, which were found to be important in detecting COVID-19 and predicting its progression, were above the reference values at the time of admission and this was consistent with the literature. The overall classification accuracy of the decision tree modeled with five variables in determining COVID-19 was 68.2%. Accordingly, 59.5% of patients with COVID-19 and 77.0% of individuals without COVID-19 were predicted correctly, and the results were promising.

ML methods, which are increasingly used effectively in Medical Services, have the ability to distinguish useful patterns in large-scale data and can identify predictors that are expected to help decision-making process in studies. As a matter of fact, in many studies for the automatic detection of the diagnosis of COVID-19 with ML models, the routine hematochemical values of patients (white blood cell count and platelet, C-reactive protein (CRP), aspartate aminotransferase, alanine aminotransaminase, lactate dehydrogenase plasma levels) were used. In these studies, it was stated that AST, CRP and lymphocyte levels are parameters to be considered and important predictive features in the diagnosis of the disease. 10, [24] [25] [26] In similar ML studies in the literature, it was reported that COVID-19 positivity was associated with lymphopenia, liver and muscle tissue damage, and significantly increased CRP. 27 In another study, a logistic regression ML model was run to identify risk factors for 4542 COVID-19 patients, and final predictors were identified and reported. In another study, in which the relationship between many laboratory values and disease was determined using data mining methods, aspartate aminotransferase, alanine aminotransaminase, calcium, sodium, potassium, creatinine and CRP were found to be associated with the risk of death. 28 Other studies using ML models found elevated neutrophil, CRP, lymphocyte and lactate dehydrogenase levels and advanced age variables as predictors of mortality associated with COVID-19 disease. 29, 30 In many studies, CHAID analysis from decision tree ML models was used as a predictor of diagnosis, prognosis and mortality in the results of these studies may assist clinicians in the diagnosis and treatment of potential COVID-19 patients. Indeed, in one study, predictors of mortality in COVID-19 patients admitted to the emergency room were determined by CHAID analysis. As a result of the study, it was stated that a high Shock Index (SI) value is an important indicator of COVID-19 mortality. 31 The SI ratio, defined as the ratio of heart rate to systolic blood pressure, is a biomarker that can be used to understand changes in cardiovascular status and tissue perfusion level. 32 Similarly, in another study using the CHAID decision tree model, the CIT (CRP × international normalized ratio × troponin) biomarker was found to be important in the diagnosis of COVID-19, while the CRP level was found to be important in predicting its prognosis. 10 The COVID-19 disease has turned into a worldwide health crisis and has caused significant problems in emergency rooms and intensive care units. Therefore, it is important to evaluate individuals who need intensive care and have high mortality expectations in the early stage of the disease (at admission), for the health system to work more efficiently. Findings related to the decision trees obtained in our study may be helpful in the early diagnosis of the disease and in the intensive care treatment of severe patients. In addition, these results are important in terms of maintaining the efficiency of the health system and reducing the pressure of time, cost and workload.

Since this study is a retrospective study obtained from registries, the inaccessibility of patients' comorbidity data and the fact that it is a single center are the limitations of this study. Since variables cannot be controlled in retrospective studies, our study data may need to be supported by prospective cohort studies. Moreover, the data used in the study were obtained from populations of COVID-19 patients in different seasons. For this reason, the parameter values in this article may have shown seasonal discrepancy from analogous studies. Studies involving larger patient groups and different centers will further clarify the importance of arterial blood gas laboratory values in the COVID-19 outbreak.

MTH: Conceived the ideas or experimental design of the study, organized the material and methodology, applied the analyses, interpreted, discussed and written, fixed the revisions; HÜ: scanned the literature, contributed to the introduction and discussion, collected the material.

Authors declare no conflict of interest.

The authors did not receive any financial support for this study. The medians and quartiles of quantitative variables are given. In order to determine which variables are effective in the diagnosis of the disease, the CHAID classification algorithm was run on intact and patient groups. The CHAID classification algorithm was run on non-ICU and ICU patient groups to determine which variables were effective in the prognosis of the disease.

Statistical methods 11 (a) Categorical variables were analyzed with the chi-square test and continuous variables were analyzed with the Mann-Whitney U test. CHAID algorithm from Decision Tree methods was used. P < 0.05 was considered statistically significant.

(b) Missing data were not included in the study 5-6 (c) After the sample is selected so that the power of the analysis is at least 80%, the CHAID classification algorithm can be run and different data can be applied.

(d) No sensitivity analysis was performed. The success of the CHAID algorithm in classifying patients was obtained by considering the real conditions of the patients.

Participants 12 (a) The number of individuals at each stage of the study was reported. 6 (b) There was no individual who stopped working for any reason. 6

Descriptive data 13 Information was given about the demographic characteristics of the study participants and possible confounders.

Outcome data 14 Results and measurements were presented according to patient groups.

Main results 15

The cut-off values of the predictor variables in determining the patient groups were obtained at 95% confidence level.

Other analyses 16 Relationships between predictors and subgroups and their interactions are presented, and the sensitivity of decision trees is reported.

Key results 17 Study objectives are cited and key results are summarized. 11-

Limitations 18

Limitations of the study are outlined and discussed, taking into account potential sources of uncertainty.

The SARS-CoV-2 outbreak: what we know

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

COVID-19 pneumonia: different respiratory treatments for different phenotypes?

Thromboinflammation and the hypercoagulability of COVID-19

Guyton and hall textbook of medical physiology. 13 th ed. Saunders

A questionaire study evaluating the knowledge and approach by physicians about arterial blood gas

Diabetic ketoacidosis and venous blood gas values

Using machine learning algorithms for breast cancer risk prediction and diagnosis

Detection of COVID-19 infection from routine blood exams with machine learning: a feasibility study

The effectiveness of blood routine parameters and some biomarkers as a potential diagnostic tool in the diagnosis and prognosis of Covid-19 disease

Coronavirus disease 2019 (COV-ID-19): a perspective from China

Loss of smell and taste in combination with other symptoms is a strong predictor of CO-VID-19 infection

Loss of smell and taste can accurately predict COVID-19 infection: a machine-learning approach

Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature

Association between age and clinical characteristics and outcomes of COVID-19

A machine learning prediction model of respiratory failure within 48 hours of patient admission for COVID-19: model development and validation

Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients

Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score

Ionized calcium

Role of methemoglobin and carboxyhemoglobin levels in predicting COVID-19 prognosis: an observational study

Endogenous carboxyhemoglobin concentrations in predicting prognosis of patients with COVID-19 Pneumonia

The role of methemoglobin and carboxyhemoglobin in COVID-19: a review

Is endogenous carboxyhaemoglobin level a useful biomarker of clinical course and prognosis in COVID-19 patients?

How do routine laboratory tests change in coronavirus disease 2019?

Clinical Characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Liver injury in COVID-19: management and challenges

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Research Square

Machine learning based clinical decision support system for early COV-ID-19 mortality prediction

An early warning tool for predicting mortality risk of COVID-19 patients using machine learning

Shock index as a predictor of mortality among the Covid-19 patients

Relationship between injury severity and lactate levels in severely injured patients

Date of submission

Date of decision

Date of acceptance

Date of web publication